Market by Display, Technology, Type, End-user, and Country Outlook | Forecast 2022-2028
A study by Triton Market Research on Europe’s cardiovascular ultrasound market shows that it would develop with a CAGR of 6.03% over the forecast period 2022-2028.
Report scope can be customized per your requirements. Request For Customization
The countries assessed in this market include:
• Spain
• France
• Germany
• Italy
• The
United Kingdom
• Rest
of Europe
Germany
is the leading market in the region, accounting for the largest share. Some of the factors contributing to the rise in
the number of cardiovascular diseases in Europe include an aging population,
changing lifestyles, and stressful work environments, among others. The growth
of the studied market is aided by government initiatives & programs that
promote the adoption of cardiac ultrasound systems.
Cardiovascular diseases (CVD) are the leading
cause of death among people in Germany, accounting for nearly 40% of all
fatalities. In 2020, close to 1,47,055 people died from coronary heart disease
(CHD) in the nation, accounting for 20.98% of overall deaths. Cardiometabolic
illnesses like diabetes mellitus, obesity, and hypertension, as well as harmful
behaviors like smoking, unhealthy dietary choices, and physical inactivity, are
among the most significant modifiable risk factors for CVD. It is crucial to
diagnose cardiovascular issues as soon as possible, which has increased the
demand for echocardiography systems. This is expected to fuel the market’s
growth.
In Italy, CVD is the leading cause of mortality
among type 2 diabetes patients, accounting for nearly 42% of all deaths.
Several factors, mainly biological, behavioral, and psychosocial, play a role
in the incidence of cardiovascular health issues. Nearly 97,116 deaths due to coronary
heart disease were reported in the country in 2020, accounting for
approximately 17.89% of all deaths. The growing prevalence of heart diseases is
prompting manufacturers to offer advanced electrocardiography systems to
patients, thus driving the market growth in the country.
3D/4D ultrasound technologies are types of
diagnostic tests that create three-dimensional or four-dimensional images or
videos of the heart, facilitating better views than those provided by 2D
technology. 3D/4D ultrasound imaging allows healthcare professionals to see
results immediately, thus reducing the waiting time for the patients as well.
The
report assesses the market based on technology, display, type, and end-user. Here, the technology segment comprises Doppler,
2D, and 3D/4D.
Mindray
Medical International Limited, Lanmage, Fujifilm Holdings Corporation, Siemens
Healthineers, Philips Healthcare, Clarius, Viatom Technology Co, and Esaote
S.p.A. are some eminent names in the cardiovascular ultrasound market.
Esaote S.p.A. is a leading manufacturer of
medical diagnostic systems. The company offers products for ultrasound, MRI
systems, healthcare IT, etc. Under the ultrasound segment, it offers products
for cardiovascular imaging, general imaging, and women’s health, among others.
As part of its ultrasound portfolio, the company provides MyLab Alpha, MyLab
X9, and some other products. Esaote S.p.A. was founded in 1982, and has its
headquarters in Genova, Italy.
Key deliverables of the report:
● Market CAGR during the forecasting years 2022-2028
● Detailed data highlighting key insights, industry components, and market strategies
● Comprehensive information and estimation of the cardiovascular ultrasound market revenue growth in Europe and its influence on the parent market
● In-depth study of forthcoming trends in consumer behavioral patterns
● A meticulous analysis of the competitive landscape, vendor scorecard, and Porter’s Five Forces Model
●
A wide-ranging study of factors that will challenge the Europe
cardiovascular ultrasound market’s growth during the upcoming years
Want to get specific insights? Our
team of analysts can customize this report based on your preferences. Connect
with us here.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. EUROPE
CARDIOVASCULAR ULTRASOUND MARKET – SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON THE CARDIOVASCULAR ULTRASOUND MARKET
2.2. KEY
INSIGHTS
2.2.1. EMERGENCE
OF ARTIFICIAL INTELLIGENCE (AI)
2.2.2. STRAIN
IMAGING HAS SEEN A GRADUAL INCREASE
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTES
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. KEY
IMPACT ANALYSIS
2.4.1. QUALITY
2.4.2. DURABILITY
2.4.3. PRICE
2.4.4. TECHNOLOGY
2.5. MARKET
ATTRACTIVENESS INDEX
2.6. VENDOR
SCORECARD
2.7. INDUSTRY
COMPONENTS
2.8. KEY
MARKET STRATEGIES
2.8.1. PRODUCT
LAUNCHES
2.8.2. ALLIANCES
2.9. MARKET
DRIVERS
2.9.1. INCREASE
IN CARDIOVASCULAR DISEASE CASES
2.9.2. ADVANCEMENTS
IN TECHNOLOGY
2.10. MARKET
CHALLENGES
2.10.1. LACK
OF AWARENESS AMONG PATIENTS
2.10.2. NEED
TO ABIDE BY STRINGENT REGULATIONS
2.11. MARKET
OPPORTUNITIES
2.11.1. RAPID
EXPANSION OF POINT-OF-CARE ULTRASOUND (POCUS)
2.11.2. RAPID
GROWTH OF FETAL ECHOCARDIOGRAPHY
3. EUROPE
CARDIOVASCULAR ULTRASOUND MARKET OUTLOOK – BY DISPLAY
3.1. BLACK
AND WHITE
3.2. COLORED
4. EUROPE
CARDIOVASCULAR ULTRASOUND MARKET OUTLOOK – BY TECHNOLOGY
4.1. 2D
4.2. 3D/4D
4.3. DOPPLER
5. EUROPE
CARDIOVASCULAR ULTRASOUND MARKET OUTLOOK – BY TYPE
5.1. TRANSTHORACIC
ECHOCARDIOGRAPHY
5.2. FETAL
ECHOCARDIOGRAPHY
5.3. TRANSESOPHAGEAL
ECHOCARDIOGRAPHY
5.4. OTHER
TYPES
6. EUROPE
CARDIOVASCULAR ULTRASOUND MARKET OUTLOOK – BY END-USER
6.1. HOSPITALS
6.2. DIAGNOSTIC
CENTERS
6.3. AMBULATORY
CARE CENTERS
6.4. OTHER
END-USERS
7. EUROPE
CARDIOVASCULAR ULTRASOUND MARKET – COUNTRY OUTLOOK
7.1. UNITED
KINGDOM
7.2. GERMANY
7.3. FRANCE
7.4. SPAIN
7.5. ITALY
7.6. REST
OF EUROPE
8. COMPETITIVE
LANDSCAPE
8.1. GE
HEALTHCARE
8.2. PHILIPS
HEALTHCARE
8.3. SIEMENS
HEALTHINEERS
8.4. CANON
MEDICAL CORP
8.5. FUJIFILM
HOLDINGS CORPORATION
8.6. SAMSUNG
MEDISON CO LTD
8.7. ESAOTE
S.P.A.
8.8. MINDRAY
MEDICAL INTERNATIONAL LIMITED
8.9. VIATOM
TECHNOLOGY CO
8.10. LANMAGE
8.11. DAWEI
MEDICAL
8.12. ZONCARE
8.13. LELTEK
INC
8.14. TELEMED
ULTRASOUND MEDICAL SYSTEMS
8.15. CLARIUS
9. RESEARCH
METHODOLOGY & SCOPE
9.1. RESEARCH
SCOPE & DELIVERABLES
9.2. SOURCES
OF DATA
9.3. RESEARCH
METHODOLOGY
TABLE 1: EUROPE CARDIOVASCULAR
ULTRASOUND MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: REGULATORY FRAMEWORK
TABLE 4: LIST OF PRODUCT
LAUNCHES
TABLE 5: LIST OF ALLIANCES
TABLE 6: EUROPE CARDIOVASCULAR
ULTRASOUND MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 7: EUROPE CARDIOVASCULAR
ULTRASOUND MARKET, BY DISPLAY, 2022-2028 (IN $ MILLION)
TABLE 8: EUROPE CARDIOVASCULAR
ULTRASOUND MARKET, BY TECHNOLOGY, 2022-2028 (IN $ MILLION)
TABLE 9: EUROPE CARDIOVASCULAR
ULTRASOUND MARKET, BY TYPE, 2022-2028 (IN $ MILLION)
TABLE 10: EUROPE
CARDIOVASCULAR ULTRASOUND MARKET, BY END-USER, 2022-2028 (IN $ MILLION)
FIGURE 1: KEY BUYING IMPACT
ANALYSIS
FIGURE 2: MARKET
ATTRACTIVENESS INDEX
FIGURE 3: INDUSTRY COMPONENTS
FIGURE 4: EUROPE
CARDIOVASCULAR ULTRASOUND MARKET, BY DISPLAY, 2021 & 2028 (IN %)
FIGURE 5: EUROPE
CARDIOVASCULAR ULTRASOUND MARKET, BY BLACK AND WHITE, 2022-2028 (IN $ MILLION)
FIGURE 6: EUROPE
CARDIOVASCULAR ULTRASOUND MARKET, BY COLORED, 2022-2028 (IN $ MILLION)
FIGURE 7: EUROPE CARDIOVASCULAR
ULTRASOUND MARKET, BY TECHNOLOGY, 2021 & 2028 (IN %)
FIGURE 8: EUROPE
CARDIOVASCULAR ULTRASOUND MARKET, BY 2D, 2022-2028 (IN $ MILLION)
FIGURE 9: EUROPE
CARDIOVASCULAR ULTRASOUND MARKET, BY 3D/4D, 2022-2028 (IN $ MILLION)
FIGURE 10: EUROPE CARDIOVASCULAR
ULTRASOUND MARKET, BY DOPPLER, 2022-2028 (IN $ MILLION)
FIGURE 11: EUROPE
CARDIOVASCULAR ULTRASOUND MARKET, BY TYPE, 2021 & 2028 (IN %)
FIGURE 12: EUROPE
CARDIOVASCULAR ULTRASOUND MARKET, BY TRANSTHORACIC ECHOCARDIOGRAPHY, 2022-2028
(IN $ MILLION)
FIGURE 13: EUROPE
CARDIOVASCULAR ULTRASOUND MARKET, BY FETAL ECHOCARDIOGRAPHY, 2022-2028 (IN $
MILLION)
FIGURE 14: EUROPE
CARDIOVASCULAR ULTRASOUND MARKET, BY TRANSESOPHAGEAL ECHOCARDIOGRAPHY,
2022-2028 (IN $ MILLION)
FIGURE 15: EUROPE
CARDIOVASCULAR ULTRASOUND MARKET, BY OTHER TYPES, 2022-2028 (IN $ MILLION)
FIGURE 16: EUROPE
CARDIOVASCULAR ULTRASOUND MARKET, BY END-USER, 2021 & 2028 (IN %)
FIGURE 17: EUROPE
CARDIOVASCULAR ULTRASOUND MARKET, BY HOSPITALS, 2022-2028 (IN $ MILLION)
FIGURE 18: EUROPE CARDIOVASCULAR
ULTRASOUND MARKET, BY DIAGNOSTIC CENTERS, 2022-2028 (IN $ MILLION)
FIGURE 19: EUROPE
CARDIOVASCULAR ULTRASOUND MARKET, BY AMBULATORY CARE CENTERS, 2022-2028 (IN $
MILLION)
FIGURE 20: EUROPE
CARDIOVASCULAR ULTRASOUND MARKET, BY OTHER END-USERS, 2022-2028 (IN $ MILLION)
FIGURE 21: EUROPE
CARDIOVASCULAR ULTRASOUND MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)
FIGURE 22: UNITED KINGDOM
CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 23: GERMANY
CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 24: FRANCE
CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 25: SPAIN
CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 26: ITALY
CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 27: REST OF EUROPE
CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)